Pharma readings

By Miguel Tovar | Miguel Tovar created a magazine on Flipboard. “Pharma readings on Flipboard” is available with thousands of other magazines and all the news you care about. Download Flipboard for free and search for “Miguel Tovar”.

Biologics: The Pricey Drugs Transforming Medicine

The following essay is reprinted with permission from The Conversation, an online publication covering the latest research.<p>In a factory just outside …

Medicine

A Drug Program That Keeps Patients Safe (And Profits, Too) - Bloomberg

For generic drug companies, manufacturing low-cost alternatives to brand-name medicines is the easy part. The hard part: getting their hands on the …

Pharma

AstraZeneca lung cancer drug combination misses goal in key study

#Market News<p>July 27, 2017 / 6:19 AM / 3 hours ago<p>1 Min Read<p>LONDON, July 27 (Reuters) - AstraZeneca's combination of two immunotherapy drugs, durvalumab and tremelimumab, failed to help patients as hoped in a closely watched advanced lung cancer trial, the British company said on Thursday. …

Cancer

Merck faces cancer drugs setback ahead of rival AstraZeneca's landmark trial results

US drugs giant Merck & Co has suffered a rare setback for its leading immuno-oncology drug Keytruda, as investors nervously await the outcome of a landmark trial for a similar cancer drug by Britain’s AstraZeneca.<p>New York-listed Merck issued a statement after markets closed last night saying …

Cancer

Stada Board Recommends Acceptance of Improved Takeover Bid

LONDON — The German generic drugmaker Stada Arzneimittel said on Tuesday that its board of directors had recommended that shareholders accept a sweetened takeover bid by the private equity firms Bain Capital and Cinven, the latest in a series of takeovers in the industry in recent years.<p>The deal, …

Eli Lilly CEO expects a Trump executive order on drug pricing this year

Eli Lilly CEO David Ricks said he expects a presidential executive order targeting drug prices this year.<p>Ricks said on an earnings call Tuesday that …

Pharma

Eli Lilly CEO Reiterates 5% Revenue Growth Target

Dave Ricks, chief executive officer at Eli Lily & Co., talks about a regulatory roadblock for a rheumatoid arthritis drug and potential risks to the …

Lilly pays Nektar $150m upfront for phase I autoimmune drug

Will add another $250m if candidate meets development objectives

Pharma

CHMP backs three immuno-oncology drugs for solid tumours

Roche, MSD and Merck/Pfizer are all on course for new European approvals later this year

Cancer

Helix Bets An 'App Store' Can Make Consumers Care About Their DNA

Is the key to getting people to want their genetic data making the experience more like the Apple App Store?<p>That’s the bet being made by Helix, a personal genomics company spun out of Illumina, the leader in making DNA sequencers. Helix, formed with $100 million in investment from Illumina, the …

DNA

Democrats take aim at big business, drug prices in new economic campaign

Democrats will begin rolling out a new economic platform on Monday in hopes of winning over President Trump's populist base with promises to take on …

Nancy Pelosi

GSK chief plans to shake up culture and competitiveness

When Emma Walmsley addressed GSK’s 100,000-strong global workforce for the first time this year, employees gathered to hear the new chief executive …

Pharma

Pay for medicines based on effectiveness, NHS told

The UK’s National Health Service should pay pharmaceutical companies for medicines based on how effectively they treat patients, according to a new …

J&J moves one step closer to a potential vaccine for HIV

Healthcare giant Johnson & Johnson is to take a big step closer to inventing a vaccine for HIV when it publishes the results of a groundbreaking clinical trial this week.<p>Sector experts believe the American firm – which is better known for selling shampoo and baby lotion – is behind the world’s most …

Medicine

New vaccine enters the battle against Aids

A new Aids vaccine will begin large-scale trials in southern Africa at the end of this year, in what is hoped will be a breaththrough in the 30-year …

Medicine

GSK boss to accelerate drug development in pharma arm

Emma Walmsley, GSK’s new chief executive, is expected to lay out plans to boost the FTSE 100 firm’s pharmaceutical division and accelerate its development of blockbuster drugs in her first set of half-year results this week.<p>Ms Walmsley, who took the helm from Sir Andrew Witty in April, made her …

Pharma

Amazon nabs a top Box exec in health as it goes after the medical industry

Amazon has landed another big health-tech hire, this time from Box.<p>Missy Krasner, vice president and managing director of Box's healthcare and life …

Digital Health

Diabetes drugmakers partner with mobile startups to boost patient engagement

Novo Nordisk's new app, Cornerstones4Care powered by Glooko(pictured above), lets user "visualize their disease," according to David Moore, the …

Diabetes

FDA tentatively approves Merck's copycat of Sanofi's Lantus

(Reuters) - Merck and Co Inc said on Thursday the U.S. Food and Drug Administration (FDA) tentatively approved its biosimilar version of French drugmaker Sanofi SA's blockbuster diabetes treatment, Lantus.<p>Merck's copycat, if launched, would challenge Lantus as a cheaper alternative that could chip …

Pharma

How to design a better clinical trial with the patient experience In mind

<i>Finding the right clinical trial can be hard for cancer patients. So can the experience of participating in one. Sometimes, it’s “almost as bad as</i> …

Clinical Trials

Pfizer CEO: The Future Of American Innovation Rests On A Competitive U.S. Tax Policy

Today I had the privilege of joining with the CEOs of Merck and Corning at the White House to announce a new type of glass packaging technology for pharmaceuticals that will provide stronger, more reliable vials and cartridges for the delivery of injectable drugs.<p>This revolutionary advance is the …

United States

EU watchdog concerned drug agency EMA may be too close to companies

LONDON (Reuters) - The European Medicines Agency (EMA), eager to accelerate access to promising new drugs, may be getting too cosy with the pharmaceutical companies it regulates.<p>That is the concern of the watchdog charged with overseeing administrative irregularities in the European Union, which is …

Medicine

When It Comes To Abusive Drug Pricing, Don't Confuse Shkreli With Hep C Drugs

Drug pricing is a topic commanding a lot of attention these days, particularly as healthcare in the U.S. is a national focus. The debate isn’t simple. The ways that drugs are distributed and paid for in this country can be best described as convoluted. Froma Harrop, a nationally syndicated, …

Pharma

Perfecting the pharmaceutical pipeline with AI

How AI can transform the way we identify and validate research

Motor Neurone Disease

Big Pharma Share Buybacks Not Impacting R&D Budgets

In her Sunday business column in the <i>New York Times</i>, Gretchen Morgenson went after Big Pharma and the propensity for companies to buy back shares of their own stocks. Entitled “When Big Pharma Spends, Research Isn’t No. 1,” Morgenson focuses on an academic study that concludes that “from 2006 …

Stocks

FDA moves to increase generic competition

New Food and Drug Administration Commissioner Dr. Scott Gottlieb knows the tricks the pharmaceutical industry often plays to increase profits.<p>His …

Sanofi: Wearables are a core part of our digital trials strategy

<b>Sanofi is looking to wearable devices to improve the way it collects data and increase the effectiveness and efficacy of its clinical trial</b> …

Digital Health
Pharma

Novo launches personalised diabetes management mobile app

<b>Novo Nordisk’s digital health deal with Glooko has yielded a new diabetes management app that the partners hope will enable users to better manage</b> …

Diabetes